<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BMJ MEDICAL MANAGEMENT, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 65-0676079
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
4800 North Federal Highway, Suite 101E, Boca Raton, Florida 33431
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A(c)(1), please check the
following box. |_|
If this Form relates to the registration of a class of debt securities and is to
become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A(c)(2), please check the following box. |_|
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
Common Stock, par value $.001 per share Nasdaq National Market
- ----------------------------------------- ----------------------------------
- ----------------------------------------- ----------------------------------
- ----------------------------------------- ----------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
NONE
Item 1. Description of Registrant's Securities to be Registered.
The Registrant's Common Stock, par value $.001 per share (the "Common
Stock") is to be registered. The description of the Common Stock will be set
forth under the caption "Description of Capital Stock" in the Registrant's
Prospectus, to be filed pursuant to Rule 424(b) under the Securities Act of 1933
and forming part of the Registrant's Registration Statement on Form S-1 (No.
333-35759), as amended, and is incorporated herein by reference.
Item 2. Exhibits.
Exhibit 1. All exhibits required by Instruction II to Item 2 will be
supplied to the Nasdaq National Market.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereto duly authorized.
BMJ MEDICAL MANAGEMENT, INC.
January 14, 1998
By: /s/ Naresh Nagpal
-------------------------------
Name: Naresh Nagpal, M.D.
Title: President and Chief Executive
Officer
